Luciana Benevides
Overview
Explore the profile of Luciana Benevides including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benevides L, Sacramento L, Pioto F, Barretto G, Carregaro V, Silva J
Front Immunol
. 2023 Nov;
14:1268196.
PMID: 37908369
In many infectious diseases, the pathogen-induced inflammatory response could result in protective immunity that should be regulated to prevent tissue damage and death. In fact, in infection, the innate immune...
2.
Azevedo P, Hojo-Souza N, Faustino L, Fumagalli M, Hirako I, Oliveira E, et al.
NPJ Vaccines
. 2023 Feb;
8(1):15.
PMID: 36781862
The current COVID-19 vaccines protect against severe disease, but are not effective in controlling replication of the Variants of Concern (VOCs). Here, we used the existing pre-clinical models of severe...
3.
da Costa L, Gardinassi L, Veras F, Milanezi C, Ramalho L, Benevides L, et al.
Arch Dermatol Res
. 2022 Aug;
315(3):481-490.
PMID: 36042041
Transcriptional factor B lymphocyte-induced maturation protein 1 (Blimp-1) is pivotally implicated in T helper 17 (Th17) cell differentiation. This study investigated expression of the Blimp-1 protein, positive regulatory domain 1...
4.
Castro J, Azevedo P, Fumagalli M, Hojo-Souza N, Salazar N, Almeida G, et al.
Nat Commun
. 2022 Aug;
13(1):4831.
PMID: 35977933
Both T cells and B cells have been shown to be generated after infection with SARS-CoV-2 yet protocols or experimental models to study one or the other are less common....
5.
Franco K, Amorim F, Santos M, Rollemberg C, de Oliveira F, Franca A, et al.
Front Immunol
. 2021 Dec;
12:779534.
PMID: 34970264
This is a case series study to evaluate immunological markers associated with schistosomiasis advanced fibrosis, including 69 patients from an endemic area from the State of Sergipe and from the...
6.
Amorim Sacramento L, Benevides L, Maruyama S, Tavares L, Fukutani K, Francozo M, et al.
PLoS Pathog
. 2020 Mar;
16(3):e1008435.
PMID: 32210480
A striking feature of human visceral leishmaniasis (VL) is chronic inflammation in the spleen and liver, and VL patients present increased production levels of multiple inflammatory mediators, which contribute to...
7.
Benevides L, Saltarelli V, Pioto F, Sacramento L, Dias M, Rodriguez G, et al.
Front Immunol
. 2019 Sep;
10:2105.
PMID: 31555297
Monocytes play key roles in the maintenance of homeostasis and in the control of the infection. Monocytes are recruited from the bone marrow to inflammatory sites and are essential for...
8.
Ketelut-Carneiro N, Souza C, Benevides L, Gardinassi L, Silva M, Tavares L, et al.
PLoS Pathog
. 2019 Aug;
15(8):e1007990.
PMID: 31425553
The granulomatous lesion resulting from infection with the fungus Paracoccidioides brasiliensis is characterized by a compact aggregate of mature cells, surrounded by a fibroblast- and collagen-rich content. Granuloma formation requires...
9.
Benevides L, Costa R, Tavares L, Russo M, Martins G, da Silva L, et al.
J Allergy Clin Immunol
. 2018 Aug;
143(3):1119-1130.e3.
PMID: 30096391
Background: The transcriptional repressor B lymphocyte-induced maturation protein 1 (Blimp-1) has a key role in terminal differentiation in various T-cell subtypes. However, whether Blimp-1 regulates T9 differentiation and its role...
10.
Marques Rossetti R, Lorenzi N, Yokochi K, Rosa M, Benevides L, Margarido P, et al.
PLoS One
. 2018 Jul;
13(7):e0199034.
PMID: 29975708
Immune evasion by tumors includes several different mechanisms, including the inefficiency of antigen presenting cells (APCs) to trigger anti-tumor T cell responses. B lymphocytes may display a pro-tumoral role but...